DJIA 18,232.02 -53.72 -0.29%
NASDAQ 5,089.36 -1.43 -0.03%
S&P 500 2,126.06 -4.76 -0.22%
market minute promo

237.53 4.26 (1.83%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

VRX $237.53 1.83%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $233.17
Previous Close $233.27
Daily Range $232.03 - $238.49
52-Week Range $106.00 - $238.49
Market Cap $81.3B
P/E Ratio 79.07
Dividend (Yield) $0.00 (0.0%)
Volume 1,945,297
Average Daily Volume 1,766,667
Current FY EPS $2.96




Drug Makers

Valeant Pharmaceuticals (VRX) Description

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology. Website:

News & Commentary

Meet the Company That May Become Healthcare's Version of Berkshire Hathaway

Warren Buffett's Berkshire Hathaway may be the most revered acquiring company on the planet, but one well-known hedge fund manager claims this company could be setting up its own Berkshire-like dominance in the healthcare sector.

Ampio Pharmaceuticals Shoots up on Positive Optina Data - Analyst Blog

Alnylam's Cardiac Amyloidosis Drug Gets Orphan Status - Analyst Blog

Hedge Funds Buy Actavis, Valeant. ETFs Join The Party

Valeant CEO: Healthcare Sector A 'Bit Of A Bubble'

Alibaba, Dollar General and 3 Other Stocks Big Hedge Funds Hated Last Quarter

5 Stocks the Biggest Hedge Funds Bought Last Quarter

Should You Get Rid of Aerie Pharmaceuticals (AERI) Now? - Tale of the Tape

6 stocks to buy...according to hedge funds

Endo to Acquire Par Pharma for $8.05B, Shares Down - Analyst Blog

Theravance Biopharma Posts Positive Data on Velusetrag - Analyst Blog

Theravance Biopharma Posts Positive Data on Velusetrag - Analyst Blog

See More VRX News...

VRX's Top Competitors

VRX $237.53 (1.83%)
Current stock: VRX
JNJ $101.35 (-1.04%)
Current stock: JNJ
NVS $103.85 (-0.90%)
Current stock: NVS
PFE $34.28 (-0.23%)
Current stock: PFE